- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-33-0293595

Syence Pharmaceuticals Private Limited
About Syence Pharmaceuticals Private Limited
Data last updated:
Syence Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 23 March 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC378959.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rashmi Jayprakash Kokate and Deepti Ramakant Narkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 10/Om Krishna Villa Green Road Louis Wadi Thane (W), Mumbai, Maharashtra, India – 400604.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.1 Lakh. For the same year it recorded a net loss of ₹5.2 Lakh (net margin -36.9%) and EBITDA of -₹3.36 Lakh (EBITDA margin -23.8%).
Syence Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0293595).
Company details
Recognitions & Rankings of Syence Pharmaceuticals
Contact details
Syence Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressA – 10/Om Krishna Villa Green Road Louis Wadi Thane (W), Mumbai, Maharashtra, India – 400604
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Syence Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Syence Pharmaceuticals Private Limited, buy the company report.
Financials of Syence Pharmaceuticals Private Limited
FY 2025 filings availableSyence Pharmaceuticals Private Limited reported revenue of ₹14.1 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.36 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹5.2 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -23.8% | |||
| Net Profit Margin | -36.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Syence Pharmaceuticals Private Limited, buy the company report.
Board of directors of Syence Pharmaceuticals Private Limited
Syence Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmi Jayprakash Kokate Also directs: Excel I - Tech Services Private Limited | Director | 23 Mar 2022 | 4 Years 7 Months | Current |
| Deepti Ramakant Narkar | Director | 23 Mar 2022 | 4 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Syence Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Syence Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Syence Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Syence Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Deepti Ramakant Narkar was appointed as Director on 23 Mar 2022.
Frequently asked questions
Syence Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 23 March 2022 (4+ years old) and is registered under CIN U24290MH2022PTC378959.
Syence Pharmaceuticals has 2 current directors:
- Rashmi Jayprakash Kokate - Director
- Deepti Ramakant Narkar - Director
The latest financial statements of Syence Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Syence Pharmaceuticals is U24290MH2022PTC378959. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syence Pharmaceuticals was incorporated on 23 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Deepti Ramakant Narkar was appointed as Director on 23 Mar 2022. Rashmi Jayprakash Kokate was appointed as Director on 23 Mar 2022.
Yes, Syence Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0293595).
The registered office of Syence Pharmaceuticals is at A – 10Om Krishna Villa Green Road Louis Wadi Thane W, Mumbai, Maharashtra, India – 400604.
Syence Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Syence Pharmaceuticals can be reached at its registered office: A – 10Om Krishna Villa Green Road Louis Wadi Thane W, Mumbai, Maharashtra, India – 400604.

